Canterbury DHB

Context

Prescribing in Pregnancy

All medicines cross the placenta to some extent.
 
When medicines are prescribed for pregnant women, either for acute or chronic conditions, weigh the potential benefits to the mother against the risk of adverse effects on the fetus/neonate.
 
Dosages of medicines may need to be adjusted during pregnancy as medicines may have altered pharmacokinetics, typically increased clearance due to increased organ blood flow and enzyme induction.

In This Section

General Advice

Effect of Medicines on Pregnancy, Fetus, or Neonate

Predictable Risks Based on Drug Activity

Effects of Pregnancy on Medicine Pharmacokinetics

General Advice

Effect of Medicines on Pregnancy, Fetus, or Neonate

Teratogenicity

Medicines with proven teratogenicity in humans

Predictable Risks Based on Drug Activity

Effects of Pregnancy on Medicine Pharmacokinetics

Information about this Canterbury DHB document (93259):

Document Owner:

Not assigned (see Who's Who)

Last Updated:

August 2022 (Prescribing in Pregnancy)

Next Review Due:

August 2023

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document.

Topic Code: 93259